Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -10.91% | -45.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.91% | -45.19% | |||
| Cost of Revenue | -55.76% | 93.55% | |||
| Gross Profit | 259.66% | -118.42% | |||
| SG&A Expenses | -12.29% | 7.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.79% | 14.34% | |||
| Operating Income | 18.61% | -30.83% | |||
| Income Before Tax | 5.90% | 6.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.90% | 6.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.90% | 6.69% | |||
| EBIT | 18.61% | -30.83% | |||
| EBITDA | 18.69% | -31.14% | |||
| EPS Basic | 0.00% | 0.00% | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | 0.00% | 0.00% | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 1.70% | 0.78% | |||
| Average Diluted Shares Outstanding | 1.70% | 0.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||